117 related articles for article (PubMed ID: 21407959)
1. Treatment of obsessive compulsive symptoms in schizophrenia with fluoxetine.
Agarwal V; Agarwal KM
Indian J Psychiatry; 2000 Jul; 42(3):291-4. PubMed ID: 21407959
[TBL] [Abstract][Full Text] [Related]
2. Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics.
Reznik I; Sirota P
J Clin Psychopharmacol; 2000 Aug; 20(4):410-6. PubMed ID: 10917401
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical correlates of obsessive-compulsive disorder in schizophrenia.
Devi S; Rao NP; Badamath S; Chandrashekhar CR; Janardhan Reddy YC
Compr Psychiatry; 2015 Jan; 56():141-8. PubMed ID: 25308405
[TBL] [Abstract][Full Text] [Related]
4. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
Berman I; Sapers BL; Chang HH; Losonczy MF; Schmildler J; Green AI
J Clin Psychopharmacol; 1995 Jun; 15(3):206-10. PubMed ID: 7635998
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
Glick ID; Poyurovsky M; Ivanova O; Koran LM
J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
Wandzel L
Psychiatr Pol; 1997; 31(4):429-35. PubMed ID: 9527686
[TBL] [Abstract][Full Text] [Related]
7. Obsessive Compulsive Symptoms/disorder in patients with schizophrenia: Prevalence, relationship with other symptom dimensions and impact on functioning.
Grover S; Dua D; Chakrabarti S; Avasthi A
Psychiatry Res; 2017 Apr; 250():277-284. PubMed ID: 28189922
[TBL] [Abstract][Full Text] [Related]
8. The impact of obsessive dimension on symptoms and functioning in schizophrenia.
Tonna M; Ottoni R; Affaticati A; Ferrari L; Monici A; Ossola P; De Panfilis C; Marchesi C
Psychiatry Res; 2015 Dec; 230(2):581-4. PubMed ID: 26471829
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of long-term fluoxetine treatment of obsessive-compulsive disorder.
Frenkel A; Rosenthal J; Nezu A; Winston A
Mt Sinai J Med; 1990 Nov; 57(6):348-52. PubMed ID: 2079952
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of high-dose escitalopram in the treatment of patients suffering from schizophrenia with comorbid obsessive-compulsive disorder: an open-label study.
Rubin-Kahana DS; Shelef A; Weizman A; Gothelf D; Timinski I; Spivak B; Stryjer R
Int Clin Psychopharmacol; 2019 Jul; 34(4):179-183. PubMed ID: 31058717
[TBL] [Abstract][Full Text] [Related]
11. Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness.
Kim SW; Jeong BO; Kim JM; Shin IS; Hwang MY; Paul Amminger G; Nelson B; Berk M; McGorry P; Yoon JS
Psychiatry Res; 2015 Mar; 226(1):368-75. PubMed ID: 25681006
[TBL] [Abstract][Full Text] [Related]
12. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
Zohar J; Kaplan Z; Benjamin J
J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
[TBL] [Abstract][Full Text] [Related]
13. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder.
Costa DLDC; Barbosa VS; Requena G; Shavitt RG; Pereira CAB; Diniz JB
J Psychopharmacol; 2017 Oct; 31(10):1312-1322. PubMed ID: 28441896
[TBL] [Abstract][Full Text] [Related]
16. [Frequency of obsessive compulsive symptoms and disorder in patients with schizophrenia: importence for prognosis].
Uçok A; Tükel R; Ozgen G; Saylan M; Uzuner G
Encephale; 2006; 32(1 Pt 1):41-4. PubMed ID: 16633289
[TBL] [Abstract][Full Text] [Related]
17. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
19. Obsessive-compulsive symptom severity in schizophrenia: a Janus Bifrons effect on functioning.
Tonna M; Ottoni R; Paglia F; Ossola P; De Panfilis C; Marchesi C
Eur Arch Psychiatry Clin Neurosci; 2016 Feb; 266(1):63-9. PubMed ID: 26048450
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive symptoms in schizophrenia: prevalance and clinical correlates.
Kayahan B; Ozturk O; Veznedaroglu B; Eraslan D
Psychiatry Clin Neurosci; 2005 Jun; 59(3):291-5. PubMed ID: 15896222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
